AT1 — Atomo Diagnostics Cashflow Statement
0.000.00%
- AU$16.26m
- AU$13.23m
- AU$3.79m
- 31
- 32
- 64
- 38
Annual cashflow statement for Atomo Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.091 | 0.005 | 0.074 | 0.913 | 1.89 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.23 | -2.81 | -5.85 | -4.69 | -1.96 |
Capital Expenditures | -5.9 | -2.31 | -0.401 | -0.016 | -0.034 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -5.9 | -2.31 | -0.401 | -0.016 | -0.034 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.997 | 0.018 | -0.171 | 1.87 | 1.46 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.16 | -4.98 | -6.5 | -2.78 | -0.468 |